Stephen T Schlachter

USPTO Granted Patents = 48 (Patent Applications = 15)

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 17 (Patent Applications = 21)

Average Co-Inventor Count = 6.9

ph-index = 10

Forward Citations = 481(Granted Patents)

Location History:

Kalamazoo, MI (US) (1995 - 1999)
Boulder, CO (US) (2000 - 2024)
Dallas, TX (US) (2015 - 2024)

Company Filing History:

Peloton Therapeutics, Inc.

Edgewise Therapeutics, Inc.

Luitpold Pharmaceuticals, Inc.

patents

9. 2 out of 2

Edgewise Therapecutics, Inc.

patents

10. 2 out of 523

Pharmacia & Upjohn Company

where one patent can have more than one assignee

Years Active: 1995-2025

Loading Chart...

48 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12448369 - Quinolinone amide compounds and uses thereof (2025-10-21),

2. 12415794 - Pyridazinone compounds and uses thereof (2025-09-16),

3. 12240833 - Pyridazinone compounds and uses thereof (2025-03-04),

4. 12240831 - Pyridazinone compounds and uses thereof (2025-03-04),

5. 12012395 - Pyridazinone compounds and uses thereof (2024-06-18),

6. RE49948 - Aryl ethers and uses thereof (2024-04-30),

7. 11390606 - Pyridazinone compounds and uses thereof (2022-07-19),

8. 11236065 - Pyridazinone compounds and uses thereof (2022-02-01),

9. 11091464 - Pyridazinone compounds and uses thereof (2021-08-17),

10. 10807948 - Aromatic compounds and uses thereof (2020-10-20),

11. 10597366 - Aryl ethers and uses thereof (2020-03-24),

12. 10144711 - Aryl ethers and uses thereof (2018-12-04),

13. 10040767 - Benzimidazole derivatives and uses thereof (2018-08-07),

14. 9969689 - Aryl ethers and uses thereof (2018-05-15),

15. 9908845 - Aryl ethers and uses thereof (2018-03-06),

As an AI assistant specializing in innovations, inventions, inventors, and patents, I can provide you with an article about inventor Stephen T Schlachter based on the data provided.

Title: Unveiling the Innovations of Stephen T Schlachter

Introduction: Stephen T Schlachter, a prolific inventor based in Dallas, TX (US), has made significant contributions in the field of pharmaceutical compositions, particularly in treating neuromuscular diseases like Duchenne Muscular Dystrophy (DMD).

Latest Patents:

1. Pyridazinone compounds and uses thereof - Stephen T Schlachter's patented invention involves substituted pyridazinone compounds, conjugates, and pharmaceutical compositions for the treatment of neuromuscular diseases such as DMD. These compounds play a crucial role in treating DMD and modulating inflammatory inhibitors IL-1, IL-6, or TNF-α.

Career Highlights:

With an impressive portfolio of 43 patents, Schlachter has established himself as a key figure in the pharmaceutical industry. He has demonstrated a profound understanding of neuromuscular diseases, paving the way for innovative treatment solutions.

Collaborations:

Throughout his career, Stephen T Schlachter has collaborated with esteemed companies such as Array Biopharma Inc. and Genentech, Inc. His partnerships with talented individuals like Rui Xu and Eli M Wallace have further enriched the realm of pharmaceutical innovations.

Conclusion:

In summary, Stephen T Schlachter's groundbreaking inventions in pharmaceutical compositions, specifically in the treatment of neuromuscular diseases, underscore his commitment to advancing healthcare solutions. His collaborative ventures and extensive patent portfolio exemplify his dedication to driving innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.